EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clostridium butyricum enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota

Ye Shiqing, Lu Xinjie, Zhu Xiaotong, Chen Jiayan, Lu Jiahai, Chen Xiaodong iD, Lou Yongliang iD, Li Xiang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.00178-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Ye Shiqing und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Clostridium butyricum, Alzheimer Disease, Cognition. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The amyloid deposition-to-cognitive impairment pathway is crucial in Alzheimer’s disease (AD) pathogenesis, with gut microbes influencing its development. Our study evaluated Clostridium butyricum MIYAIRI 588 (CBM588) as a potential AD treatment. In APP/PS1 mice, CBM588 improved cognitive function and alleviated colonic tissue pathology by modulating tight junction proteins (upregulating Claudin 1, ZO-1, and Occludin) and reducing inflammatory cytokines (IL-6, IL-1β, and TNF-α mRNA). It also reduced Aβ plaque deposition in the brain, regulated the JNK/CDK5/GSK-3β pathway to inhibit Tau hyperphosphorylation, and maintained neuronal integrity by downregulating Bax/Bcl-2 and inflammatory cytokines, thereby inhibiting apoptosis. While not altering the overall gut flora structure, CBM588 increased acetate-producing bacteria and decreased pro-inflammatory genera, reducing lipopolysaccharide levels. It also elevated short-chain fatty acids, particularly acetate, in colonic feces and brain tissue. Sodium acetate further inhibited BV2 cell apoptosis by suppressing JAK/STAT signaling and reducing Aβ and p-Tau expressions. In conclusion, CBM588 holds great potential as a novel probiotic for AD control. IMPORTANCE The current study underscores the pivotal role of gut microbiota modulation in the treatment of Alzheimer’s disease(AD). Our comprehensive evaluation of CBM588 demonstrates its remarkable potential to ameliorate cognitive impairment in APP/PS1 mice by modulating gut microbiota composition, upregulating short-chain fatty acids, particularly acetate, and mitigating neuroinflammation. These findings not only provide novel insights into the gut-brain axis in AD but also offer a promising therapeutic strategy, highlighting the importance of targeting gut microbiota in future AD research and interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeClostridium butyricumAlzheimer DiseaseCognitionProbioticsAnimalsMiceBrainDisease Models, AnimalCytokinesMaleMice, TransgenicAmyloid beta-Protein PrecursorCognitive DysfunctionAmyloid beta-PeptidesPresenilin-1Colon

Stichwörter der Autor:innen

Alzheimer’s diseaseClostridium butyricumintestinal microbiotaneuroinflammationshort-chain fatty acid

Substanzen

CytokinesAmyloid beta-Protein PrecursorAmyloid beta-PeptidesPresenilin-1

Autor:innen und Institutionen

  • Wenzhou Key Laboratory of Sanitary Microbiology, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Institute of One Health, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Neurology, Linyi Women & Children's Healthcare Hospital, The First Affiliated Hospital of Shandong Medical College, Linyi, Shandong, China.

ORCID-Profile: Chen Xiaodong, Lou Yongliang, Li Xiang

Zitieren

APA

Shiqing, Y., Xinjie, L., Xiaotong, Z., Jiayan, C., Jiahai, L., Xiaodong, C., Yongliang, L., & Xiang, L. (2025). Clostridium butyricum enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00178-25

Vancouver

Shiqing Y, Xinjie L, Xiaotong Z, Jiayan C, Jiahai L, Xiaodong C, et al. Clostridium butyricum enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00178-25

BibTeX
@article{Shiqing2025,
  author = {Shiqing, Ye and Xinjie, Lu and Xiaotong, Zhu and Jiayan, Chen and Jiahai, Lu and Xiaodong, Chen and Yongliang, Lou and Xiang, Li},
  title = {Clostridium butyricum enhances cognitive function in APP/PS1 mice by modulating neuropathology and regulating acetic acid levels in the gut microbiota},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.00178-25}
}
Kostenlos starten →